Company Filing History:
4 out of 3,446 
1 out of 832,812 Years Active: 2004-2015
Title: Sandra Steiner: Innovator in Opsonophagocytosis Enhancement
Introduction
Sandra Steiner is a prominent inventor based in Atlanta, GA (US). She has made significant contributions to the field of immunology, particularly in enhancing opsonophagocytosis in response to pathogens. With a total of 5 patents to her name, her work has the potential to impact therapeutic strategies against infectious diseases.
Latest Patents
One of Sandra's latest patents focuses on the use of a pneumococcal P4 peptide for enhancing opsonophagocytosis. The methods disclosed in this patent include administering an isolated P4 peptide, which contains a specific amino acid sequence, to a subject. This peptide can be combined with an isolated opsonic antibody or its fragment that binds to antigens on the pathogen's surface. Additionally, the patent discusses the administration of isolated complement proteins or their fragments, such as C3a, C3b, iC3b, C3d, C4b, or C5a, to further enhance the immune response.
Career Highlights
Throughout her career, Sandra has worked with esteemed organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services. Her experience in these institutions has allowed her to develop innovative solutions in the field of immunology.
Collaborations
Sandra has collaborated with notable colleagues, including George M. Carlone and Gowrisankar Rajam. These partnerships have contributed to her research and the advancement of her patented technologies.
Conclusion
Sandra Steiner is a trailblazer in the field of immunology, with her innovative patents paving the way for new therapeutic approaches. Her work exemplifies the importance of research and collaboration in addressing public health challenges.